Consumer Perceptions of Safety Information in Direct-to-Consumer Print Advertisements for Alzheimer Drugs

Jenny Markell; Ilina Odouard; Gerard F Anderson; Michael J DiStefano

doi:10.1001/jamanetworkopen.2024.31110

Consumer Perceptions of Safety Information in Direct-to-Consumer Print Advertisements for Alzheimer Drugs

JAMA Netw Open. 2024 Aug 1;7(8):e2431110. doi: 10.1001/jamanetworkopen.2024.31110.

Authors

Jenny Markell¹, Ilina Odouard¹, Gerard F Anderson¹, Michael J DiStefano²

Affiliations

¹ Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
² Center for Pharmaceutical Outcomes Research, Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora.

No abstract available

Plain language summary

This survey study assesses the effectiveness of drug advertisement to shape perception of the benefits and risks of and personal willingness to use and recommend an advertised drug.

MeSH terms

Adult
Aged
Alzheimer Disease* / drug therapy
Direct-to-Consumer Advertising* / methods
Female
Humans
Male
Middle Aged
Surveys and Questionnaires
United States